CYHB2302813 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs(4) | Supplementary Application | 2023-12-30 | | Shanghai DESANO Biopharmaceutical Co Ltd | | | view |
JYHS2300031 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2023-02-22 | | | | | view |
JYHS2300030 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2023-02-22 | | | | | view |
JTH2200240 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Disposable Import Drug Application | 2022-12-21 | | | | | view |
JYHZ2200202 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | License Renew | 2022-07-18 | | | | | view |
CYHS2200758 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs(4) | Generic Drug | 2022-05-25 | | Anhui Biochem Bio-Pharmaceutical Co Ltd | | | view |
CYHS2200484 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs(4) | Generic Drug | 2022-03-24 | | Shanghai DESANO Biopharmaceutical Co Ltd | | | view |
JYHZ2100595 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | License Renew | 2021-08-05 | | | | | view |
JYHB2001606 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2020-08-28 | AbbVie Deutschland GmbH & Co.KG | Abbvie Deutschland Gmbh & Co KG | Certificate Issued | 2020-11-24 | view |
JYHB2001605 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2020-08-28 | AbbVie Deutschland GmbH & Co.KG | Abbvie Deutschland Gmbh & Co KG | Certificate Issued | 2020-11-24 | view |
JYHB2000638 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2020-05-27 | AbbVie Deutschland GmbH & Co.KG | Abbvie Deutschland Gmbh & Co KG | Filed | 2020-06-09 | view |
JYHB2000637 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2020-05-27 | AbbVie Deutschland GmbH & Co.KG | Abbvie Deutschland Gmbh & Co KG | Filed | 2020-06-09 | view |
JYHB1901349 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2019-11-13 | AbbVie Deutschland GmbH & Co.KG | Abbvie Deutschland Gmbh & Co KG | Certificate Issued | 2020-01-20 | view |
JYHB1901350 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2019-11-13 | AbbVie Deutschland GmbH & Co.KG | Abbvie Deutschland Gmbh & Co KG | Certificate Issued | 2020-01-20 | view |
JYHB1900177 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2019-02-12 | AbbVie Deutschland GmbH & Co. KG | Abbvie Deutschland Gmbh & Co KG | Certificate Issued | 2019-09-23 | view |
JYHB1900178 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2019-02-12 | AbbVie Deutschland GmbH & Co. KG | Abbvie Deutschland Gmbh & Co KG | Certificate Issued | 2019-09-23 | view |
JYHB1701091 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2017-08-21 | AbbVie Ltd. | Abbvie Ltd | In Review | 2017-08-19 | view |
JYHZ1700275 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | License Renew | 2017-08-21 | AbbVie Ltd. | Abbvie Ltd | Certificate Issued | 2018-03-19 | view |
JYHB1700866 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2017-06-19 | AbbVie Ltd. | Abbvie Ltd | Filed | 2017-09-12 | view |
JYHB1700865 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2017-06-19 | AbbVie Ltd. | Abbvie Ltd | Filed | 2017-07-17 | view |